Company / Net Debt per Share
Fortress Biotech, Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.97
FY2025
5-year range
-$2.77 / $0.05
FY2021-FY2025
Trend
-2186.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share changed -2186% YoY in FY2025, a notable deviation from the 9-year average annual change of -286%.
Based on SEC 10-K filings.
-0.97 in FY2025.
Increased from $-2.72 to $-0.97 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net debt per share decreased 2186.1% year-over-year.
- Peak net debt per share was recorded in FY2018.
- Lowest net debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.97 | -2186.1% |
| FY2024 | $0.05 | +101.7% |
| FY2023 | -$2.72 | -219.4% |
| FY2022 | -$0.85 | +69.2% |
| FY2021 | -$2.77 | -292.8% |
| FY2020 | -$0.71 | +13.4% |
| FY2019 | -$0.81 | -319.8% |
| FY2018 | $0.37 | +187.4% |
| FY2017 | -$0.42 | +70.6% |
| FY2016 | -$1.44 | +11.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026